Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The soluble guanylate cyclase activator runcaciguat signi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial
0
Authors
Ron Gansevoort
9 more
Ron Gansevoort
•
David Wheeler
7 more
•
Roland Schmieder
Published
December 3, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nephrology Dialysis Transplantation
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Urology
Show all topics
DOI
10.1093/ndt/gfae261
License
CC-BY-NC
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nephrology Dialysis Transplantation
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Urology
Show all topics
DOI
10.1093/ndt/gfae261
License
CC-BY-NC
Other Formats
PDF
